Hsbc Holdings PLC Hutchmed (China) LTD Transaction History

Hsbc Holdings PLC

$145 Billion
Q1 2024

A detailed history of Hsbc Holdings PLC transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Hsbc Holdings PLC holds 183,766 shares of HCM stock, worth $3.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

183,766

Previous 206,544 11.03%

Holding current value

$3.15 Million

Previous $3.74 Million 17.46%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$12.08 - $18.56 $275,158 - $422,759	-22,778 Reduced 11.03%	183,766 $3.09 Million
Q4 2023 Feb 12, 2024	BUY	$16.25 - $20.23 $2.99 Million - $3.72 Million	184,123 Added 821.21%	206,544 $3.74 Million
Q3 2023 Nov 13, 2023	BUY	$11.85 - $16.95 $265,688 - $380,035	22,421 New	22,421 $379,000
Q3 2022 Nov 14, 2022	SELL	$8.63 - $15.52 $23,551 - $42,354	-2,729 Reduced 2.54%	104,504 $926,000
Q2 2022 Aug 11, 2022	BUY	$8.59 - $20.77 $101,928 - $246,456	11,866 Added 12.44%	107,233 $1.36 Million

Q1 2022 May 16, 2022	BUY	$15.52 - $35.65 $372,976 - $856,740	24,032 Added 33.69%	95,367 $1.81 Million
Q4 2021 Feb 11, 2022	SELL	$28.89 - $35.33 $133,847 - $163,683	-4,633 Reduced 6.1%	71,335 $2.5 Million
Q3 2021 Nov 12, 2021	BUY	$35.66 - $42.94 $582,613 - $701,553	16,338 Added 27.4%	75,968 $2.78 Million
Q2 2021 Aug 13, 2021	BUY	$23.7 - $39.27 $33,061 - $54,781	1,395 Added 2.4%	59,630 $2.34 Million
Q1 2021 May 14, 2021	BUY	$27.01 - $36.8 $24,309 - $33,120	900 Added 1.57%	58,235 $1.65 Million
Q4 2020 Feb 12, 2021	BUY	$27.51 - $34.36 $125,418 - $156,647	4,559 Added 8.64%	57,335 $1.84 Million
Q3 2020 Nov 12, 2020	BUY	$25.8 - $34.61 $824,671 - $1.11 Million	31,964 Added 153.58%	52,776 $1.71 Million
Q2 2020 Aug 14, 2020	SELL	$17.65 - $28.05 $718,019 - $1.14 Million	-40,681 Reduced 66.16%	20,812 $574,000
Q1 2020 May 15, 2020	SELL	$15.19 - $29.51 $526,667 - $1.02 Million	-34,672 Reduced 36.05%	61,493 $1.1 Million
Q4 2019 Feb 14, 2020	BUY	$17.17 - $25.95 $204,168 - $308,571	11,891 Added 14.11%	96,165 $2.41 Million
Q3 2019 Nov 14, 2019	BUY	$17.84 - $22.69 $32,433 - $41,250	1,818 Added 2.2%	84,274 $1.5 Million
Q2 2019 Aug 13, 2019	BUY	$22.0 - $31.78 $327,206 - $472,663	14,873 Added 22.01%	82,456 $1.81 Million
Q1 2019 May 15, 2019	BUY	$21.27 - $30.58 $1.11 Million - $1.6 Million	52,159 Added 338.17%	67,583 $2.07 Million
Q4 2018 Feb 13, 2019	BUY	$23.09 - $37.69 $356,140 - $581,330	15,424 New	15,424 $356,000
Q1 2018 May 11, 2018	SELL	$28.87 - $41.13 $1.87 Million - $2.66 Million	-64,753 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$27.41 - $39.42 $1.77 Million - $2.55 Million	64,753	64,753 $2.55 Million

Others Institutions Holding HCM

# of Institutions

Shares Held

14M

Call Options Held

2.7K

Put Options Held

3.7K

View Full List

About HUTCHMED (China) Ltd

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.96B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

More about HCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Hutchmed (China) LTD Transaction History